CompletedPhase 4ketamine

Intra-nasal Ketamine for Analgesia in the Emergency Department

Sponsored by Lions Gate Hospital

NCT ID
NCT01686009
Target Enrollment
40 participants
Start Date
2012-10
Est. Completion
2013-01

About This Study

The provision of analgesia to patients in pain is a fundamental necessity of emergency department practice and is usually accomplished using IV opioids. However, significant barriers exist to the provision of timely analgesia by the IV route. The use of the IN route for medication delivery provides an efficient and relatively painless mode of analgesia delivery. As well, ketamine is well-known to be an effective analgesic and to preserve cardiorespiratory function thus removing the necessity of physiologic monitoring that is obligatory when using opioids. The use of ketamine by the IN route provides a rapid, easy-administered and well-tolerated method for providing analgesia in the ED setting.

Conditions Studied

Pain

Interventions

  • Intra-nasal ketamine

Eligibility

Age:6 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* age 6 years or greater
* moderate or severe pain (VAS \>=50mm)

Exclusion Criteria:

* history of allergy or intolerance to ketamine
* structural or functional nasal occlusion
* inability to understand the VAS
* Glasgow Coma Scale \< 15
* Systolic BP \> 180
* History of schizophrenia
* Clinical necessity for immediate IV access as judged by the treating physician

Study Locations (1)

Lions Gate Hospital
North Vancouver, British Columbia, Canada

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source